Skip to main content
. 2022 Mar 15;14(3):2123–2132.

Table 2.

Hemoglobin and transferrin positive rates among the 122 normal subjects and 51 colorectal cancer patients

Cases, n Hb, n (%) Tf, n (%) Hb+Tf, n (%)
Normal 122 8 (6.56) 7 (5.74) 13 (10.66)
CRC 51 45 (88.24) 33 (64.71) 48 (94.12)*

Patients were subjected to two fecal sample tests, and the larger value was collected. Cutoffs were 100 ng/mL (10 µg/g feces) for hemoglobin (Hb), 25 ng/mL (2.5 µg/g feces) for transferrin (Tf).

*

P < 0.05.

CRC: colorectal cancer.